Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast

被引:48
|
作者
Ringberg, A [1 ]
Idvall, I
Fernö, M
Anderson, H
Anagnostaki, L
Boiesen, P
Bondesson, L
Holm, E
Johansson, S
Lindholm, K
Ljungberg, O
Östberg, G
机构
[1] Malmo Univ Hosp, Dept Plast & Reconstruct Surg, S-20502 Malmo, Sweden
[2] Malmo Univ Hosp, Dept Pathol & Cytol, S-20502 Malmo, Sweden
[3] Univ Lund Hosp, Dept Pathol & Cytol, S-22185 Lund, Sweden
[4] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden
[5] Univ Lund Hosp, Dept Canc Epidemiol, S-22185 Lund, Sweden
[6] Hosp Helsingborg, Dept Pathol & Cytol, Helsingborg, Sweden
[7] Hosp Karlskrona, Dept Pathol & Cytol, Karlskrona, Sweden
[8] Hosp Vaxjo, Dept Pathol & Cytol, Vaxjo, Sweden
[9] Hosp Kristianstad, Dept Pathol & Cytol, Kristianstad, Sweden
[10] Hosp Halmstad, Dept Pathol & Cytol, Halmstad, Sweden
来源
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY | 2000年 / 26卷 / 05期
关键词
breast cancer; in situ; nuclear grade; margin; growth pattern; prognosis; treatment; DCIS;
D O I
10.1053/ejso.1999.0919
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Method and Results: A standardized histopathological protocol has been designed, in which different histological characteristics of ductal carcinoma in situ (DCIS) are reported. nuclear grade (ng), growth pattern acccording to Andersen et nl., necrosis, size of the lesion, resection margins and focality. Using this protocol a re-evaluation of a population-based consecutive series of 306 cases of DCIS has been done as well as a thorough clinical follow-up. After a median follow-up of 63 months, 13% have developed ipsilateral local recurrences, invasive and/or in situ. Ipsilateral local recurrence-free survival (IL-RFS) was significantly better for patients operated with mastectomy (ME) or breast conserving therapy (BCT) with radiotherapy (RT) than for patients operated with BCT without RT (5-year IL-RFS 96% vs 94% vs 79%, P<0.001). In the subgroup of BCT without RT there were significant differences in IL-RFS between histopathological subgroups: ng 1 + 2 (non-high grade) vs ng 3 thigh grade; P = 0.014), non-high-grade without comedo-type necrosis vs non-high-grade with comedo-type necrosis vs high-grade (the Van Nuys classification system; P=0.025). Growth pattern (not diffuse vs diffuse) and margins (free vs involved or not evaluated) showed a tendency (P=0.07 and 0.05, respectively) to be associated to IL-RFS. In contrast, no significant differences in IL-RFS were found in subgroups based on mode of detection, focality or size. Ninety-four per cent of the local recurrences after BCT appeared at the previous operation site. Conclusions: In the BCT without RT group, combinations of either nun-high grade and not a diffuse growth pattern or non-high grade and free margins identified groups (constituting approximately 30% of the patients) were at low risk of developing ipsilateral recurrences (6-10%), compared to a 31-37% recurrence risk in the remaining groups during the observed follow-up time. The beneficial effect of post-operative RT for these low-risk groups can be questioned, and should be studied further. (C) 2000 Harcourt Publishers Ltd.
引用
收藏
页码:444 / 451
页数:8
相关论文
共 50 条
  • [21] Radiation therapy delay and risk of ipsilateral breast tumors in women with ductal carcinoma in situ
    Liu, Ying
    Yun, Shumei
    Lian, Min
    Colditz, Graham
    CANCER RESEARCH, 2016, 76
  • [22] Frequency of Breast Conserving Therapy Following an Ipsilateral Local Relapse in Patients With Ductal Carcinoma In Situ (DCIS) Treated With Lumpectomy (L) ± Radiation Therapy (RT)
    Miller, D.
    Shan-Chin, C.
    Boolbol, S. K.
    Gillego, A.
    Boachie-Adjei, K.
    Harrison, L. B.
    Chadha, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S197 - S197
  • [24] Morphological heterogeneity in ductal carcinoma in situ of the breast
    Pop, C. Stanciu
    Nollevaux, M-C.
    Berliere, M.
    Duhoux, F.
    Van Bockstal, M. R.
    ANNALS OF ONCOLOGY, 2020, 31 : S28 - S29
  • [25] Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy
    Adepoju, LJ
    Symmans, WF
    Babiera, GV
    Singletary, SE
    Arun, B
    Sneige, N
    Pusztai, L
    Buchholz, TA
    Sahin, A
    Hunt, KK
    Meric-Bernstam, F
    Ross, MI
    Ames, FC
    Kuerer, HM
    CANCER, 2006, 106 (01) : 42 - 50
  • [26] Macrophage density is an adverse prognosticator for ipsilateral recurrence in ductal carcinoma in situ
    Darvishian, Farbod
    Wu, Yinxiang
    Ozerdem, Ugur
    Chun, Jennifer
    Adams, Sylvia
    Guth, Amber
    Axelrod, Deborah
    Shapiro, Richard
    Troxel, Andrea B.
    Schnabel, Freya
    Roses, Daniel
    BREAST, 2022, 64 : 35 - 40
  • [27] Outcome after invasive recurrence in patients with ductal carcinoma in situ of the breast
    Romero, L
    Klein, L
    Ye, W
    Holmes, D
    Soni, R
    Silberman, H
    Lagios, MD
    Silverstein, MJ
    AMERICAN JOURNAL OF SURGERY, 2004, 188 (04): : 371 - 376
  • [28] Outcome after invasive recurrence in patients with ductal carcinoma in situ of the breast
    Holmes, D. R.
    Romero, L.
    Klein, L.
    Soni, R.
    Lagios, M.
    EJC SUPPLEMENTS, 2004, 2 (03): : 189 - 189
  • [29] Invasive local recurrence increased after radiation therapy for ductal carcinoma in situ
    Guerra, Lisa E.
    Smith, Robina M.
    Kaminski, Anna
    Lagios, Michael D.
    Silverstein, Melvin J.
    AMERICAN JOURNAL OF SURGERY, 2008, 196 (04): : 552 - 555
  • [30] Are cellular polarisation and mitotic frequency prognostic factors for local recurrence in patients with ductal carcinoma in situ of the breast?
    Idvall, I
    Anderson, H
    Ringberg, A
    Fernö, M
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (12) : 1704 - 1710